Already a Bloomberg.com user?
Sign in with the same account.
ANNCARE BIO-TECH said unconsolidated sales in February rose 82.78% to NT$18,322,000 from NT$10,024,000, according to a statement filed to the Taiwan Stock Exchange.
(Figures are in thousands of New Taiwan dollars)
2/2012 2/2011 Sales 18,322 10,024 YOY% 82.78%
-----------------Year-to-date----------------- Sales 32,105 24,199 YOY% 32.67% =================================================================